Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall

Vicenta Cázares-Domínguez1, Ariadnna Cruz-Córdova1, Sara A Ochoa1

  • 1Laboratorio de Investigación en Bacteriología Intestinal, Hospital Infantil de México Federico Gómez, Dr. Márquez 162, Col. Doctores, Delegación Cuauhtémoc, México D.F., México.

Plos One
|March 21, 2015
PubMed

Insights

Vancomycin-tolerant MRSA (Methicillin-resistant Staphylococcus aureus) in children shows thicker cell walls, indicating adaptive resistance. This finding is crucial for understanding and treating persistent MRSA infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pathogen Resistance

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant opportunistic pathogen causing various infections.
  • Increasing vancomycin resistance necessitates understanding resistance mechanisms in MRSA.
  • Vancomycin tolerance (VT) and heterogeneous vancomycin-intermediate S. aureus (hVISA) phenotypes are growing concerns.

Purpose of the Study:

  • To investigate the impact of vancomycin on cell wall thickening in clinical vancomycin-tolerant MRSA isolates from pediatric patients.
  • To characterize the genetic and phenotypic traits of these vancomycin-tolerant MRSA isolates.

Main Methods:

  • Isolation and characterization of vancomycin-tolerant MRSA from pediatric clinical samples.
  • Multiplex-PCR for agr group and SCCmec typing.
  • Pulsed-field gel electrophoresis (PFGE) for genetic relatedness.
  • Transmission electron microscopy (TEM) to analyze cell wall thickness.

Main Results:

  • 12% of MRSA isolates were vancomycin-tolerant (VT-MRSA), with 41.66% exhibiting the hVISA phenotype.
  • VT-MRSA isolates were predominantly associated with agr group II (66.66%) and SCCmec group II (83.3%).
  • TEM analysis revealed a significant average increase of 24 nm (105.55%) in cell wall thickness in VT-MRSA compared to controls.

Conclusions:

  • Thickened cell walls in VT-MRSA, particularly those with agr type II and SCCmec group II, are linked to adaptive vancomycin resistance.
  • These findings highlight a potential mechanism for vancomycin tolerance in pediatric MRSA infections.
  • Understanding cell wall alterations is critical for developing strategies against resistant MRSA strains.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
113
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
57
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
143
Bacterial Cell Wall01:22

Bacterial Cell Wall

The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
5.5K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
76
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
100